These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16099427)

  • 1. Anthrax edema factor potency depends on mode of cell entry.
    Hong J; Beeler J; Zhukovskaya NL; He W; Tang WJ; Rosner MR
    Biochem Biophys Res Commun; 2005 Sep; 335(3):850-7. PubMed ID: 16099427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and analysis of biological activity of the recombination anthrax edema factor].
    Dong DY; Xu JJ; Song XH; Fu L; Chen W
    Wei Sheng Wu Xue Bao; 2005 Jun; 45(3):459-62. PubMed ID: 15989247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for adjuvanticity of anthrax edema toxin.
    Quesnel-Hellmann A; Cleret A; Vidal DR; Tournier JN
    Vaccine; 2006 Feb; 24(6):699-702. PubMed ID: 16168529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of biologically active Bacillus anthracis edema factor in Escherichia coli.
    Cooksey BA; Sampey GC; Pierre JL; Zhang X; Karwoski JD; Choi GH; Laird MW
    Biotechnol Prog; 2004; 20(6):1651-9. PubMed ID: 15575695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a small molecule that inhibits the interaction of anthrax edema factor with its cellular activator, calmodulin.
    Lee YS; Bergson P; He WS; Mrksich M; Tang WJ
    Chem Biol; 2004 Aug; 11(8):1139-46. PubMed ID: 15324815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MD simulations of anthrax edema factor: calmodulin complexes with mutations in the edema factor "switch a" region and docking of 3'-deoxy ATP into the adenylyl cyclase active site of wild-type and mutant edema factor variants.
    Zhao J; Roy SA; Nelson DJ
    J Biomol Struct Dyn; 2003 Oct; 21(2):159-70. PubMed ID: 12956602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells.
    Maldonado-Arocho FJ; Fulcher JA; Lee B; Bradley KA
    Mol Microbiol; 2006 Jul; 61(2):324-37. PubMed ID: 16856939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulation of host signalling pathways by anthrax toxins.
    Turk BE
    Biochem J; 2007 Mar; 402(3):405-17. PubMed ID: 17313374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Femtomolar detection of the anthrax edema factor in human and animal plasma.
    Duriez E; Goossens PL; Becher F; Ezan E
    Anal Chem; 2009 Jul; 81(14):5935-41. PubMed ID: 19522516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an edema factor-mediated cAMP-induction bioassay for detecting antibody-mediated neutralization of anthrax protective antigen.
    Zmuda JF; Zhang L; Richards T; Pham Q; Zukauskas D; Pierre JL; Laird MW; Askins J; Choi GH
    J Immunol Methods; 2005 Mar; 298(1-2):47-60. PubMed ID: 15847796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP imaging of cells treated with pertussis toxin, cholera toxin, and anthrax edema toxin.
    Dal Molin F; Zornetta I; Puhar A; Tonello F; Zaccolo M; Montecucco C
    Biochem Biophys Res Commun; 2008 Nov; 376(2):429-33. PubMed ID: 18793614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion protein of Delta 27LFn and EFn has the potential as a novel anthrax toxin inhibitor.
    Kong Y; Guo Q; Yu C; Dong D; Zhao J; Cai C; Hou L; Song X; Fu L; Xu J; Chen W
    FEBS Lett; 2009 Apr; 583(8):1257-60. PubMed ID: 19332063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of Bacillus anthracis edema factor.
    Seifert R; Dove S
    Pharmacol Ther; 2013 Nov; 140(2):200-12. PubMed ID: 23850654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a domain in Bordetella pertussis adenylyl cyclase important for subunit interactions and cell invasion activity.
    Oldenburg DJ; Storm DR
    Microb Pathog; 1993 Aug; 15(2):153-7. PubMed ID: 8255208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP conformations and ion binding modes in the active site of anthrax edema factor: a computational analysis.
    Martínez L; Laine E; Malliavin TE; Nilges M; Blondel A
    Proteins; 2009 Dec; 77(4):971-83. PubMed ID: 19705488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
    Gupta M; Alam S; Bhatnagar R
    Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet aggregation by anthrax edema toxin.
    Alam S; Gupta M; Bhatnagar R
    Biochem Biophys Res Commun; 2006 Jan; 339(1):107-14. PubMed ID: 16293226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
    Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numerous distinct PKA-, or EPAC-based, signalling complexes allow selective phosphodiesterase 3 and phosphodiesterase 4 coordination of cell adhesion.
    Raymond DR; Wilson LS; Carter RL; Maurice DH
    Cell Signal; 2007 Dec; 19(12):2507-18. PubMed ID: 17884339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and screening of small molecule inhibitors of anthrax edema factor.
    Jimenez ME; Bush K; Pawlik J; Sower L; Peterson JW; Gilbertson SR
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4215-8. PubMed ID: 18539457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.